| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2541 | Quetiapine Fumarate, Form-I | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2015-153 - Rev 04 | 2025/11/17 | Valid | Chemical | 2025/11/17 | Notification|CEP granted|17/11/2025; Minor revision|Accepted - CEP remains valid|22/08/2025; Minor revision|CEP granted|05/12/2024; Minor revision|Accepted - CEP remains valid|28/11/2023; Minor revision|CEP granted|15/06/2023; Minor revision|CEP granted|26/10/2022; Renewal|CEP granted|05/04/2022; Major revision|CEP granted|04/11/2021; Minor revision|Rejected|22/02/2021 |
||
| 1670 | Glutathione | SHANDONG JINCHENG BIO-PHARMACEUTICAL CO. LTD. Zibo CN | 100039047;100061447 | CEP 2024-255 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 1012 | Famotidine, FM3 Process | IPCA LABORATORIES LIMITED Mumbai IN | 100011685;100018680 | CEP 2022-213 - Rev 02 | 2025/11/14 | Valid | 18/01/2028 | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Minor revision|CEP granted|20/10/2023; New application|CEP granted|18/01/2023 |
|
| 2191 | Atorvastatin calcium, Form-I | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2018-049 - Rev 04 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|19/05/2025; Minor revision|Accepted - CEP remains valid|19/08/2024; Major revision|CEP granted|26/04/2024; Monograph revision|CEP granted|24/03/2023; Major revision|Rejected|28/03/2022 |
||
| 1653 | Potassium clavulanate, diluted, Microcrystalline cellulose 1:1 blend | SMITHKLINE BEECHAM LIMITED Irvine GB | 100000119;100003201 | CEP 2005-244 - Rev 02 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Minor revision|Accepted - CEP remains valid|30/09/2020 |
||
| 2787 | Esomeprazole magnesium dihydrate | LEE PHARMA LIMITED Hyderabad IN | 100014849;100042625 | CEP 2021-334 - Rev 01 | 2025/11/14 | Valid | 03/05/2027 | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; New application|CEP granted|03/05/2022 |
|
| 388 | Dexamethasone | TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN | 100011805;100018616 | CEP 2015-205 - Rev 01 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|16/08/2021 |
||
| 1484 | Levocabastine hydrochloride, Process Part 2 | KATSURA CHEMICAL CO., LTD. Zama JP | 100025070;100034253 | CEP 2018-217 - Rev 02 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|02/09/2024; Minor revision|Accepted - CEP remains valid|02/09/2022 |
||
| 1408 | Cilastatin sodium, Sterile | SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou CN | 100014777;100050265 | CEP 2025-103 - Rev 00 | 2025/11/14 | Valid | 14/11/2030 | Chemical | 2025/11/14 | New application|CEP granted|14/11/2025 | |
| 576 | Allopurinol, Site-II | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2025-441 - Rev 00 | 2025/11/14 | Valid | 14/11/2030 | Chemical | 2025/11/14 | New application|CEP granted|14/11/2025 | |
| 3132 | Mirabegron | MEGAFINE PHARMA PRIVATE LIMITED Mumbai IN | 100011550;100021133 | CEP 2024-087 - Rev 02 | 2025/11/14 | Valid | 28/03/2030 | Chemical | 2025/11/14 | Administrative procedure|CEP granted|14/11/2025; Major revision|CEP granted|03/11/2025; New application|CEP granted|28/03/2025 |
|
| 1556 | Piretanide, Micronised | ZENTIVA K.S. Prague CZ | 100004108;100097772 | CEP 2024-234 - Rev 00 | 2025/11/14 | Valid | 14/11/2030 | Chemical | 2025/11/14 | New application|CEP granted|14/11/2025 | |
| 1688 | Articaine hydrochloride | SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City CN | 100048410;100080174 | CEP 2023-255 - Rev 01 | 2025/11/13 | Valid | 03/01/2030 | Chemical | 2025/11/13 | Minor revision|CEP granted|13/11/2025; New application|CEP granted|03/01/2025 |
|
| 2857 | Trazodone hydrochloride, Process-II, Milled/Unmilled | INTAS PHARMACEUTICALS LIMITED Ahmedabad IN | 100011529;100023432 | CEP 2025-141 - Rev 00 | 2025/11/13 | Valid | 13/11/2030 | Chemical | 2025/11/13 | New application|CEP granted|13/11/2025 | |
| 926 | Levonorgestrel, Non-micronised and micronised | HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou City CN | 100015482;100024200 | CEP 2022-199 - Rev 01 | 2025/11/13 | Valid | 19/05/2028 | Chemical | 2025/11/13 | Minor revision|CEP granted|13/11/2025; New application|CEP granted|19/05/2023 |
|
| 2223 | Glimepiride, Micronised | USV PRIVATE LIMITED Mumbai IN | 100006251;100010851 | CEP 2023-130 - Rev 01 | 2025/11/13 | Valid | 07/11/2028 | Chemical | 2025/11/13 | Minor revision|CEP granted|13/11/2025; New application|CEP granted|07/11/2023 |
|
| 2779 | Solifenacin succinate, Process II, form-I, micronised and non-micronised | ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN | 100006039;100002980 | CEP 2025-401 - Rev 00 | 2025/11/13 | Valid | 13/11/2030 | Chemical | 2025/11/13 | New application|CEP granted|13/11/2025 | |
| 521 | Phenytoin sodium | HARMAN FINOCHEM LIMITED Mumbai IN | 100011528;100020515 | CEP 2016-038 - Rev 01 | 2025/11/13 | Valid | Chemical | 2025/11/13 | Minor revision|CEP granted|13/11/2025; Renewal|CEP granted|11/01/2023; Notification|CEP granted|01/03/2021; Minor revision|CEP granted|24/07/2020 |
||
| 2127 | Clobetasol propionate, Micronised, non-micronised | FARMABIOS S.p.A Gropello Cairoli IT | 100011643;100021232 | CEP 2011-135 - Rev 04 | 2025/11/13 | Valid | Chemical | 2025/11/13 | Major revision|CEP granted|13/11/2025; Administrative procedure|CEP granted|17/12/2021; Minor revision|CEP granted|10/12/2021; Monograph revision|Accepted - CEP remains valid|16/07/2020 |
||
| 2736 | Imatinib mesilate, Form-β | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou CN | 100014719;100023221 | CEP 2023-303 - Rev 01 | 2025/11/12 | Valid | 05/03/2030 | Chemical | 2025/11/12 | Minor revision|CEP granted|12/11/2025; New application|CEP granted|05/03/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号